Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens

Clinical trial NCT02625155 · UNKNOWN

Trial details

NCT number: NCT02625155
Sponsor: InSource Diagnostics
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Target Drug-related Adverse Events

Start date: 2015-12-01
Primary completion: 2018-12-01
Enrollment: 14000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.